Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer
- 1 May 2021
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 600, 120532
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Eukaryotic Initiation Factor 2α - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to TreatmentPLOS ONE, 2013
- Rac signaling in breast cancer: A tale of GEFs and GAPsCellular Signalling, 2012
- Doxorubicin-Loaded (PEG)3-PLA Nanopolymersomes: Effect of Solvents and Process Parameters on Formulation Development andIn VitroStudyMolecular Pharmaceutics, 2011
- Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to ApplicationsNano Letters, 2010
- On the mechanism of formation of vesicles from poly(ethylene oxide)-block-poly(caprolactone) copolymersSoft Matter, 2009
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007
- Effect of Poly(acrylic acid) Block Length Distribution on Polystyrene-b-Poly(acrylic acid) Aggregates in Solution. 1. VesiclesLangmuir, 2003
- Anthracycline Efficacy in vitro: Cytotoxicity of Liposomal/Nonliposomal Daunorubicin and Doxorubicin for Multiple Tumor Cell TypesDrug Delivery, 1997
- Guanabenz A Review of its Pharmacodynamic Properties and Therapeutic Efficacy in HypertensionDrugs, 1983
- The Solubility of Ethyl Acetate in WaterJournal of the American Chemical Society, 1953